White Papers
-
Continuous Manufacturing For API Breakthroughs
3/17/2026
Observe how a compound library, designed for chemical diversity and lead-like properties, uses advanced filtering to improve hit discovery, speed hit-to-lead development, and boost early-stage small molecule drug discovery.
-
Continuous Flow — An Emerging Alternative
3/17/2026
Gain insights on transitioning from batch to continuous flow processes, the benefits of continuous flow chemistry, and ensuring regulatory compliance with Quality by Design (QbD) principles.
-
Small Molecule API Production: Unveiling The Impact Of Fermentation
3/17/2026
Technological developments have led to growth in the suitability of fermentation for a myriad of applications. Explore the impact of the evolution of synthetic biology and supporting technologies on modern fermentation practice.
-
Accelerated API Manufacturing: Combining All Process Development Stages
3/17/2026
During early-stage development, utilize the key considerations outlined in this paper to avoid common pitfalls and expedite the transition from molecule to market.
-
A Guide To Process Transparency In Custom Lab Automation Development
3/16/2026
Discover a practical guide to building custom automation systems with clarity and confidence, as well as how transparent processes reduce risk, prevent misalignment, and support reliable testing.
-
Don't Let Formulation Failures Derail Drug Development
3/13/2026
In the face of increasing molecular complexity, early developability assessment with a skilled CDMO can reduce pharmaceutical development costs, prevent clinical delays, and improve commercial success.
-
Patented Process For Intermediates Useful For Etrasimod Arginine
3/13/2026
Explore how rethinking the synthetic strategy for Etrasimod can overcome the limitations of legacy routes, enabling more efficient chirality control, improved scalability, and more practical industrial API production.
-
Patented Process For Intermediates Useful For Deucravacitinib
3/13/2026
Discover how this patented synthetic approach to Deucravacitinib intermediates can improve yield, simplify purification, and support scalable, regulatory-aligned manufacturing.
-
Transformative Innovation: Advancing Drug Development Using In Silico Modeling
3/4/2026
Explore how predictive modeling and in silico strategies can turn complex data into actionable insights that accelerate drug development and reduce risk across the development lifecycle.
-
Alleviate Compliance Risks With Your EAM/CMMS
3/2/2026
Discover how unified asset management enhances audit readiness by connecting maintenance, calibration, and quality insights, as well as how integrated workflows reduce compliance risk.